Subspecialties: Page 1205

Triple-rule-out CT yields even contrast enhancement

By Eric Barnes

Researchers in Florida have developed a triphasic multidetector-row CT (MDCT) method for ruling out the three most dangerous causes of chest pain. Their 64-slice CT protocol examines the coronary arteries, pulmonary arteries, and the aortic arch in a single pass, generating even contrast enhancement in all three regions.

January 21, 2007

Korean rads find no edge for high-res CR in chest exams

By Brian Casey

A new study from Korea found that radiologists reading chest studies on PACS workstations do just as well with standard-resolution computed radiography (CR) as they do with a high-resolution version of CR. The researchers sought to determine if high-resolution CR translated into improved diagnostic accuracy for radiologists in a conventional PACS environment.

January 21, 2007

Bayer Schering to develop PET brain imaging agents

By AuntMinnie.com staff writers

Berlin-based Bayer Schering Pharma (formerly Schering) has signed a license and option agreement with two Japanese companies and the National Institute of Radiological Sciences (NIRS) in Japan to develop imaging compounds for detecting neurodegenerative diseases such as Alzheimer's and Parkinson's diseases.

January 18, 2007

MR arthrography depicts tears, instability in triangular fibrocartilage complex

By Shalmali Pal

The triangular fibrocartilage complex (TFCC) is the main stabilizer of the distal radioulnar joint, and when injuries occur in the form of tears, the latter will influence imaging outcome. But these tears may go unseen on traditional MRI and/or arthroscopy. Several studies assessed the usefulness of MR arthrography in peripheral tears and in cases of carpal instability.

January 18, 2007

Cook donates $2 million to Baptist-Miami

By AuntMinnie.com staff writers

Interventional firm Cook has donated $2 million to the Baptist Cardiac & Vascular Institute Foundation in Miami to establish the Barry T. Katzen Medical Director Endowment Fund at the facility.

January 17, 2007

FDA OKs longer shelf life for Taxus

By AuntMinnie.com staff writers

Interventional device developer Boston Scientific said that the U.S. Food and Drug Administration has approved extending the shelf life of its Taxus Express² paclitaxel-eluting coronary stent system from 12 months to 18 months.

January 17, 2007

Siemens extends Biosense Webster deal

By AuntMinnie.com staff writers

Cardiac technology developer Biosense Webster of Diamond Bar, CA, a Johnson & Johnson subsidiary, has been granted exclusive worldwide rights to distribute the Acuson AcuNav ultrasound catheter from Siemens Medical Solutions to interventional cardiologists.

January 17, 2007

New tracer shows promise for PET/CT prostate imaging

By Jonathan S. Batchelor

One in six men in the U.S. will get prostate cancer during his lifetime, according to recent data. Unfortunately, conventional imaging techniques are limited for detecting, staging, and restaging this carcinoma. But a study by scientists at Emory University in Atlanta and researchers in Japan finds that a new radiotracer shows promse in evaluating and staging prostate cancer.

January 17, 2007

Multiple MR protocols pose triple threat in prostate cancer screening

By Shalmali Pal

Prostate cancer screening with a combination of MR techniques can accurately detect and localize prostate cancer -- and possibly avoid needless biopsy, according to researchers from Tokyo. They used three different image interpretation protocols and found that each one offered something unique in prostate cancer detection.

January 17, 2007

AuntMinnie.com MarketStat #46: Cath lab device budgets for 2006

As of IMV's 2006 Cardiac Cath Census Survey, 21% of the cath labs had device budgets of less than $200K, 23% had $200K-$599K budgets, 13% had $600K-$999K budgets, and 43% had device budgets of $1 million or more.

January 17, 2007

Neoprobe gets FDA nod for more Lymphoseek trials

By AuntMinnie.com staff writers

Gamma camera probe developer Neoprobe has received authorization from the U.S. Food and Drug Administration (FDA) to begin patient enrollment in two phase I clinical studies for its Lymphoseek targeting agent.

January 16, 2007

German screening trial finds high accuracy for VC

By Eric Barnes

Results from the first 300 patients screened in the ongoing Munich Colorectal Cancer Prevention Trial indicate that virtual colonoscopy with 64-slice CT is sensitive and specific for the detection of polyps of all sizes. The researchers in Germany found that conventional colonoscopy had a slight edge in diminutive polyps, but virtual colonoscopy did a little better with the larger lesions.

January 16, 2007

Previous Page

Page 1205 of 1553

Next Page